We've all seen them: 30-second television ads from attorneys, targeting those who've had a negative side effect after using a ...

The Food and Drug Administration approved the drug — also known by its chemical name elinzanetant — for treatment of women suffering from moderate to severe hot flashes related to menopause, Bayer ...

NORTHAMPTON, MA / ACCESS Newswire / November 4, 2025 / Public policies are central factors in determining healthcare interventions and access to medicines and treatment. Viatris leverages our global ...

Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Study Overview: Bayer AG is conducting an observational study titled ...

Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Bayer AG, in collaboration with Janssen Research & Development, LLC, has ...

The company’s Moderate operating performance and financial health, combined with its High valuation, make the stock appear ...

TV ads from lawyers warning about “bad drugs” could be putting lives at risk, according to the Cornell Chronicle. A new Cornell study found that when older adults see legal ads targeting blood ...

As part of its commitment to advancing national drug security, Mubadala Bio has introduced eight new essential medicines in ...

Dear Toni: Currently, I am on a stand-alone Part D plan with a Medicare supplement because of my serious health issues. Last week, I received information about the 2026 changes to the Medicare Part D ...

Mubadala Bio begins local manufacturing of eight essential medicines in the UAE, cutting import reliance and improving supply ...

Lupin share price fell 1 percent in the opening trade on October 6 following the company received four observations to its Pithampur unit from USFDA. At 09:25 hrs Lupin was quoting at Rs 1,952.35, ...